Innovation Centre Allows Members to Sample I4.0 Technology Demonstrated in a GMP Environmen

20 February 2020

GMP News

A new Innovation Centre has been opened in Dublin, Ireland, by the National Institute for Bioprocessing Research and Training (NIBRT) and Boston Consulting Group (BCG) as part of the Biopharma 4.0 (B4.0) Alliance.

The facility will be dedicated to biopharma operations and showcase the latest Industry 4.0 (I4.0) technologies in biopharma manufacturing, bioprocessing, quality control and training. According to the NIBRT, the technologies are integrated with core operating processes to enable proof-of-concept use cases on new discoveries and ways of working, situated in a good manufacturing practice (GMP) simulated environment.

The organisation says that implementing these methodologies in the biopharma and bioprocessing industries could lead to productivity improvements of up to 40 percent. Whilst Europe has typically been a leader in biopharma innovation, as a whole it is behind others and the adoption of next generation technologies is key to maintaining this advantage, says the NIBRT.

The centre allows visitors and members to sample I4.0 technology demonstrated in a GMP environment and also allows companies to co-create or pilot digital solutions to their specific challenges.

Source

Print

Shareholders

Read more

Pipeline

Read more

Media Center

Read more